EpiVax's Grant - XXI Round

EpiVax raised a round of funding on July 30, 2012. Investors include National Heart Lung and Blood Institute.

EpiVax, is a privately held biotechnology company focused on the development of vaccines and immunotherapies for infectious diseases, autoimmunity and cancer. The immunoinformatics team at EpiVax has …

Articles about EpiVax's Grant - XXI Round: